Peripheral Intervention Market - Trends Forecast Till 2028

Market Overview

The global peripheral intervention market is anticipated to reach USD 4.32 billion by 2020 growing at a CAGR of 8.9% during the forecasting period, 2020-2028. Peripheral intervention helps in removing the plaque and restoring the blood flow through the artery. These interventions are medical specialties that help in treating peripheral artery diseases without surgically opening the leg or arm. Factors such as rising demand for minimally invasive and non-invasive surgical procedures and increasing demand for the early detection of peripheral artery diseases and coronary diseases are some of the major drivers for the peripheral intervention market

Key Findings

The global peripheral intervention market is segmented into type, procedures, end-user, and geography.

The type segment is segmented into angioplasty procedure, angioplasty with stent, angioplasty balloons, IVS filters, evar stent-grafts, accessory devices, catheters, plaque modification device, hemodynamic flow alteration.

Procedures segment is segmented into oncology procedures, neurology, uternal, hepatic, renal, gastric, skin procedures

The end-User segment is segmented into hospitals, surgical centers, specialty centers, and others

Geographically, the global peripheral intervention market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.

Regional Analysis

North America region is the largest contributor to the peripheral intervention market in the forecast period 2020-2028.

Competitive Landscape

Key players in the global peripheral intervention market are Angioscore Ltd., Abbott Vascular, Cordis Corp., Boston Scientific, C.R. Bard Inc., Cook Medical, Medtronic Inc., Volcano Corporation, Terumo Interventional Systems Inc., Teleflex Medical, W.L.Gore & Associates Ltd., ST. Jude Medical, Bayer, Edward Lifesciences, Covidien among others

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

• In 2019, Abbott has announced to acquire Cephea Valve Technologies Inc., which is engaged in developing a minimally invasive mitral valve replacement system. 
• In 2019, Medtronic has announced the launch of Telescope (TM) Guide Extension Catheter which would help in supporting the Complex Coronary Cases

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
• Gain authentic and granular data access for peripheral intervention market to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope